Treace Medical Concepts, Inc.

Stock ticker:
TMCI

On November 15, 2022, Culper Research issued a short report on Treace Medical Concepts, Inc., alleging that Treace’s Lapiplasty surgical kits do not represent a medical advancement, but instead rely on aggressive reimbursement practices and deceptive direct to consumer marketing practices.

Shares of Treace Medical Concepts, Inc. stock dropped more than 14% in intraday trading on November 15, 2022.

Download Complaint

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.